Rallybio Corporation (RLYB)

NCM – Real Time Price. Currency in USD

16.33

-0.05 (-0.31%)

Market open: Aug 12, 2026, 10:27 AM EDT

16.51

+0.13 (0.79%)

Previous after-hours: Aug 11, 2026, 5:13 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

858K

636K

Cost of goods sold

-92K

-131K

-150K

-167K

Gross Profit

766K

505K

-150K

-167K

Operating expenses (excl. COGS)

-29M

-61M

-79M

-68M

Operating Income

-28M

-60M

-79M

-68M

Non-operating income, total

20M

Pretax income

-8M

-56M

-73M

-66M

Equity in earnings

-874K

-2M

-1M

Taxes

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-9M

-58M

-75M

-67M

Discontinued operations

Net income

-9M

-58M

-75M

-67M

Dilution adjustment

Preferred dividends

Rallybio Corporation (RLYB)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Rallybio Corporation (RLYB)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Rallybio Corporation (RLYB)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Rallybio Corporation (RLYB)

Income Statement (Annual)

Income Statement (Annual)